Nothing Special   »   [go: up one dir, main page]

Grbic et al., 2011 - Google Patents

In vitro–in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation

Grbic et al., 2011

View PDF
Document ID
2024452750523782662
Author
Grbic S
Parojcic J
Ibric S
Djuric Z
Publication year
Publication venue
Aaps Pharmscitech

External Links

Snippet

The aim of this study was to develop a drug-specific absorption model for gliclazide (GLK) using mechanistic gastrointestinal simulation technology (GIST) implemented in GastroPlus TM software package. A range of experimentally determined, in silico predicted or literature …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/20—Handling natural language data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/15—Medicinal preparations; Physical properties thereof, e.g. dissolubility

Similar Documents

Publication Publication Date Title
Grbic et al. In vitro–in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation
Dahan et al. Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs
O'Dwyer et al. In vitro methods to assess drug precipitation in the fasted small intestine–a PEARRL review
Chavda et al. Biopharmaceutics classification system
Pathak et al. Model-based analysis of biopharmaceutic experiments to improve mechanistic oral absorption modeling: an integrated in vitro in vivo extrapolation perspective using ketoconazole as a model drug
Stillhart et al. PBPK absorption modeling: establishing the in vitro–in vivo link—industry perspective
Anand et al. Dissolution testing for generic drugs: an FDA perspective
Dickinson et al. Clinical relevance of dissolution testing in quality by design
Reddy et al. Biopharmaceutics classification system: a regulatory approach
García-Arieta et al. Bioequivalence requirements in the European Union: critical discussion
Wu et al. Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs
Borbás et al. Prediction of bioequivalence and food effect using flux-and solubility-based methods
Li et al. Justification of biowaiver and dissolution rate specifications for piroxicam immediate release products based on physiologically based pharmacokinetic modeling: An in-depth analysis
Cardot et al. Implementing the biopharmaceutics classification system in drug development: reconciling similarities, differences, and shared challenges in the EMA and US-FDA-recommended approaches
Daublain et al. Analyzing the potential root causes of variability of pharmacokinetics in preclinical species
Lionberger et al. Use of partial AUC to demonstrate bioequivalence of zolpidem tartrate extended release formulations
Yasuji et al. The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control
Jede et al. Improved prediction of in vivo supersaturation and precipitation of poorly soluble weakly basic drugs using a biorelevant bicarbonate buffer in a gastrointestinal transfer model
Friedel et al. FIP guidelines for dissolution testing of solid oral products
Xia et al. Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound
Zhu et al. Utilizing in vitro dissolution-permeation chamber for the quantitative prediction of pH-dependent drug-drug interactions with acid-reducing agents: a comparison with physiologically based pharmacokinetic modeling
Jereb et al. In vitro–in vivo relationship and bioequivalence prediction for modified-release capsules based on a PBPK absorption model
Kiyota et al. Importance of gastric secretion and the rapid gastric emptying of ingested water along the lesser curvature (“Magenstraße”) in predicting the in vivo performance of liquid oral dosage forms in the fed state using a modeling and simulation
Kollipara et al. In vitro and In silico biopharmaceutic regulatory guidelines for generic bioequivalence for oral products: Comparison among various regulatory agencies
Zhang et al. In silico modeling and simulation to guide bioequivalence testing for oral drugs in a virtual population